This afternoon Dexcom announced they have acquired TypeZero. Per a company issued press release;
“DexCom, Inc. (NASDAQ:DXCM), the leader in continuous glucose monitoring for people with diabetes, announced today that it has acquired TypeZero Technologies, Inc. (“TypeZero”). TypeZero’s offering includes the inControl diabetes management system, designed to provide personalized diabetes management solutions including technology to automatically adjust and regulate insulin delivery.”
While there is a plethora of insulin dosing algorithms we have always viewed the TypeZero algorithm as one of the best, if not the best. Note that the coming Tandem closed loop system which will compete directly . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.